review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0889-8529(18)30121-X |
P698 | PubMed publication ID | 7913021 |
P2093 | author name string | Grauer A | |
Raue F | |||
Frank-Raue K | |||
P2860 | cites work | A REVIEW OF 17 CASES OF CARCINOMA OF THE THYROID AND PHAEOCHROMOCYTOMA | Q24561690 |
Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma | Q30411356 | ||
Multiple mucosal neuromata with endocrine tumours: a syndrome allied to von Recklinghausen's disease | Q34224725 | ||
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. | Q34334980 | ||
Early diagnosis of the multiple endocrine neoplasia type 2 syndrome: consensus statement. European Community Concerted Action: Medullary Thyroid Carcinoma | Q35275653 | ||
Incidence of sporadic and familial medullary thyroid carcinoma in Sweden 1959 through 1981. A nationwide study in 126 patients. Swedish MCT Study Group | Q38056139 | ||
Medullary carcinoma of thyroid. Biologic behavior of the sporadic and familial neoplasm | Q38520681 | ||
Advances in the diagnosis and treatment of medullary thyroid carcinoma. | Q39462141 | ||
C-cell disease of the thyroid gland in multiple endocrine neoplasia, type 2B | Q39824843 | ||
Current concepts. Pheochromocytoma: diagnosis, localization and management | Q40095614 | ||
Adrenal medullary disease in multiple endocrine neoplasia, type 2: pheochromocytoma and its precursors | Q41059646 | ||
Multiple Endocrine Neoplasia Type IIb: The Most Aggressive Form of Medullary Thyroid Carcinoma | Q41591754 | ||
Importance of early diagnosis and follow-up in multiple endocrine neoplasia (MEN II B). | Q42248203 | ||
Preoperative diagnosis of occult parathyroid hyperplasia by calcium infusion in patients with multiple endocrine neoplasia, type 2a | Q42445792 | ||
Differences between sporadic pheochromocytoma and pheochromocytoma in multiple endocrine neoplasia, type 2 | Q72424148 | ||
Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity | Q78516362 | ||
Familial endocrine tumors; report of two unrelated kindred affected with pheochromocytomas, one also with multiple thyroid carcinomas | Q79373120 | ||
Calcitonin and PDN-21 as tumour markers in MEN-2 family screening for medullary thyroid carcinoma | Q42453110 | ||
Chromogranin A as tumor marker in medullary thyroid carcinoma | Q42453379 | ||
Evaluation of sensitive PDN-21 (katacalcin) determination as tumor marker in medullary thyroid carcinoma | Q42460217 | ||
Multiple endocrine syndrome type IIb in early childhood | Q42473107 | ||
Results of a screening program for C-cell disease (medullary thyroid cancer and C-cell hyperplasia). | Q42483809 | ||
Diagnosis of medullary carcinoma of the thyroid (MCT) by calcitonin assay using monoclonal antibodies: criteria for the pentagastrin stimulation test in hereditary MCT. | Q42485855 | ||
Somatostatin in medullary thyroid cancer. In vitro and in vivo studies. | Q42494558 | ||
Hereditary localized pruritus in affected members of a kindred with multiple endocrine neoplasia type 2A (Sipple's syndrome). | Q42494889 | ||
Calcitonin gene-related peptide and calcitonin as tumour markers in MEN 2 family screening | Q42495031 | ||
Medullary carcinoma in children. Results of early detection and surgery | Q42498682 | ||
Diagnostic evaluation of measurements of carboxyl-terminal flanking peptide (PDN-21) of the human calcitonin gene in human serum | Q42527568 | ||
Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy | Q44737758 | ||
Presymptomatic screening for multiple endocrine neoplasia type 2A with linked DNA markers. The MEN 2A International Collaborative Group | Q44951307 | ||
Multiple endocrine neoplasia IIb: an unusual cause of chronic constipation | Q45048569 | ||
Screening for multiple endocrine neoplasia type 2a with DNA-polymorphism analysis | Q46812588 | ||
A kindred with multiple endocrine neoplasia type 2A associated with pruritic skin lesions | Q46955094 | ||
Stimulation of thyrocalcitonin secretion by pentagastrin and calcium in 2 patients with medullary carcinoma of the thyroid | Q48019135 | ||
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. | Q48114164 | ||
The occurrence of multiple endocrine neoplasia type IIb, in two children of an affected mother. | Q51789075 | ||
Cushing's syndrome caused by ACTH- and calcitonin-secreting medullary carcinoma of the thyroid. | Q53839590 | ||
A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10 | Q55670968 | ||
The association of pheochromocytoma with carcinoma of the thyroid gland | Q56211630 | ||
Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage | Q57319205 | ||
The Natural Course of Multiple Endocrine Neoplasia Type iib | Q62978399 | ||
Multiple endocrine neoplasia syndrome type 2: The value of screening and central registration | Q62978432 | ||
Medullary carcinoma of the thyroid gland | Q66908748 | ||
Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970 | Q67582013 | ||
Epidemiology of medullary carcinoma of the thyroid gland: a 5-year experience (1971-1976) | Q67664931 | ||
Diagnostic relevance of the amino-terminal cleavage peptide of procalcitonin (PAS-57), calcitonin and calcitonin gene-related peptide in medullary thyroid carcinoma patients | Q67936617 | ||
Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2 | Q68729988 | ||
[Katacalcin--a new tumor marker in C-cell cancer of the thyroid gland] | Q68945338 | ||
Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content | Q69015456 | ||
Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy | Q69247020 | ||
Clinical characteristics in sporadic and familial medullary thyroid carcinoma. A nationwide study of 249 patients in Sweden from 1959 through 1981 | Q69367581 | ||
Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis | Q69376131 | ||
Sipple's syndrome: medullary thyroid carcinoma, pheochromocytoma, and parathyroid disease. Studies in a large family. NIH conference | Q69383028 | ||
Medullary thyroid carcinoma. The need for early diagnosis and total thyroidectomy | Q69771884 | ||
Results of early thyroidectomy for medullary thyroid carcinoma in children with multiple endocrine neoplasia type 2 | Q69891636 | ||
Risk estimation and screening in families of patients with medullary thyroid carcinoma | Q69912692 | ||
The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience | Q69912831 | ||
C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors | Q69922188 | ||
The importance of early diagnosis in patients with hereditary medullary thyroid carcinoma | Q70329549 | ||
Early Diagnosis of Medullary Carcinoma of the Thyroid Gland by Means of Calcitonin Assay | Q70537361 | ||
Bilateral occurrence of pheochromocytoma in patients with the multiple endocrine neoplasia syndrome type 2A (Sipple's syndrome) | Q70782484 | ||
Spectrum of pheochromocytoma in multiple endocrine neoplasia. A scintigraphic portrayal using 131I-metaiodobenzylguanidine | Q70783989 | ||
Familial medullary thyroid carcinoma and C cell hyperplasia | Q70938789 | ||
Medullary thyroid carcinoma: prognostic factors and treatment | Q71687294 | ||
Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register | Q72213388 | ||
P433 | issue | 1 | |
P921 | main subject | multiple endocrine neoplasia | Q1553018 |
P304 | page(s) | 137-156 | |
P577 | publication date | 1994-03-01 | |
P1433 | published in | Endocrinology and Metabolism Clinics of North America | Q15763298 |
P1476 | title | Multiple endocrine neoplasia type 2. Clinical features and screening | |
P478 | volume | 23 |
Q74127799 | A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma |
Q36722002 | Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey |
Q37785239 | Endocrine Cancer Predisposition Syndromes: Hereditary Paraganglioma, Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia Type 2, and Hereditary Thyroid Cancer |
Q40975238 | Evaluation and management of the solid thyroid nodule. |
Q33706700 | Factors predicting outcome of total thyroidectomy in young patients with multiple endocrine neoplasia type 2: a nationwide long-term follow-up study |
Q35692908 | Hyperaldosteronism and pheochromocytoma: new tricks and tests |
Q36179244 | Lessons from genes mutated in multiple endocrine neoplasia (MEN) syndromes. |
Q74453797 | Molecular Screening for RET Proto-Oncogene Mutations in a German MEN2A Pedigree |
Q83912480 | Multiple endocrine neoplasia 2B presenting with pseudo-Hirschsprung's disease |
Q46795959 | Multiple endocrine neoplasia type 2A/localized cutaneous lichen amyloidosis associated with malignant pheochromocytoma and ganglioneuroma |
Q34253160 | Multiple endocrine neoplasia type 2B--genetic basis and clinical expression |
Q34209934 | Old and new insights in the treatment of thyroid carcinoma. |
Q84961635 | Pheochromocytoma: diagnostic and therapeutic update |
Q38614500 | Pheochromocytomas in Multiple Endocrine Neoplasia Type 2. |
Q42524637 | Prophylactic thyroidectomy in MEN 2A syndrome: experience in a single center |
Q44035070 | Ret proto-oncogene mutations in apparently sporadic Turkish medullary thyroid carcinoma patients: Turkmen study |
Q79448269 | Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients |
Q74454035 | Simultaneous medullary and papillary microcarcinoma of thyroid in a patient with secondary hyperparathyroidism |
Q77735581 | Surgery for Hyperparathyroidism |
Q33587939 | The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2 |
Q41202108 | Thyroid cancer in children, pregnant women, and patients with Graves' disease |
Q37678245 | Update multiple endocrine neoplasia type 2. |
Q85653523 | [Endocrine tumors: clinical overview] |
Search more.